|
Status |
Public on Dec 18, 2013 |
Title |
ulcerative colitis colon mucosa 509 |
Sample type |
genomic |
|
|
Source name |
colon mucosa 509, after treatment with 6-mercaptopurine and mesalamine
|
Organism |
Homo sapiens |
Characteristics |
gender: Male age (y): 13 tissue: Colon mucosa disease state: ulcerative colitis treatment: 6-mercaptopurine and mesalamine
|
Extracted molecule |
genomic DNA |
Extraction protocol |
Genomic DNA was extracted and purified from colon mucosa samples using QIAamp DNA Mini Kit (Qiagen, Valencia, CA) starting at step 5 of the Tissue Protocol following bead beating and Qiagen TissueLyser treatment. All samples were quality tested with PicoGreen prior to proceeding with the microarrays.
|
Label |
Cy5 and Cy3
|
Label protocol |
Standard Illumina protocol
|
|
|
Hybridization protocol |
Bisulfite converted DNA was amplified, fragmented and hybridized to the Illumina Infinium HumanMethylation450 BeadChip using standard Illumina protocol
|
Scan protocol |
Arrays were imaged using BeadArray Reader using standard recommended Illumina scanner settings
|
Description |
Ulcerative colitis treated with 6-mercaptopurine and mesalamine colon mucosa sample.
|
Data processing |
GenomeStudio software version 2010.3.0.30128
|
|
|
Submission date |
Dec 17, 2013 |
Last update date |
Dec 18, 2013 |
Contact name |
R. Alan Harris |
E-mail(s) |
[email protected]
|
Organization name |
Baylor College of Medicine
|
Department |
Molecular and Human Genetics
|
Street address |
1 Baylor Plaza
|
City |
Houston |
State/province |
TX |
ZIP/Postal code |
77030 |
Country |
USA |
|
|
Platform ID |
GPL13534 |
Series (2) |
GSE32146 |
DNA methylation in a discovery cohort of colon mucosa samples from individuals with Crohns' disease or ulcerative colitis and normal controls |
GSE32149 |
DNA methylation in Crohns' disease and ulcerative colitis |
|